{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:38:43Z","timestamp":1785577123846,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.transci.2021.103066","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T22:38:08Z","timestamp":1610577488000},"page":"103066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Establishment of a cell processing laboratory to support hematopoietic stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy"],"prefix":"10.1016","volume":"60","author":[{"given":"Somnath","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opal","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Panch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8b","key":"10.1016\/j.transci.2021.103066_bib0005","doi-asserted-by":"crossref","DOI":"10.7196\/SAMJ.2019.v109i8b.013888","article-title":"Haematopoietic stem cell transplantation in South Africa: current limitations and future perspectives","volume":"109","author":"Grobbelaar","year":"2019","journal-title":"S Afr Med J"},{"issue":"11","key":"10.1016\/j.transci.2021.103066_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transci.2021.103066_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbmt.2016.09.002","article-title":"Chimeric antigen receptor t cells and hematopoietic cell transplantation: how not to put the CART before the horse","volume":"23","author":"Kenderian","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103066_bib0020","series-title":"CIBMTR summary slides: HCT trends and survival data [Internet]","year":"2020"},{"issue":"11","key":"10.1016\/j.transci.2021.103066_bib0025","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the american society for blood and marrow transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.transci.2021.103066_bib0030","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.hoc.2019.05.006","article-title":"Advances in T-cell immunotherapies","volume":"33","author":"Stroncek","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 3","key":"10.1016\/j.transci.2021.103066_bib0035","first-page":"35","article-title":"Collection and use of stem cells; role of transfusion centers in bone marrow transplantation","volume":"67","author":"McCullough","year":"1994","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.transci.2021.103066_bib0040","first-page":"6","article-title":"CAR T-Cell therapy: update on the state of the science","volume":"23","author":"Lamprecht","year":"2019","journal-title":"Clin J Oncol Nurs"},{"issue":"4","key":"10.1016\/j.transci.2021.103066_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11899-019-00529-5","article-title":"Overcoming challenges in process development of cellular therapies","volume":"14","author":"Highfill","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"issue":"Suppl 2","key":"10.1016\/j.transci.2021.103066_bib0050","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41409-019-0604-3","article-title":"The role of allogeneic HSCT after CAR T cells for acute lymphoblastic leukemia","volume":"54","author":"Jacoby","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"241","key":"10.1016\/j.transci.2021.103066_bib0055","article-title":"Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies","volume":"12","author":"Stroncek","year":"2014","journal-title":"J Transl Med"},{"issue":"150","key":"10.1016\/j.transci.2021.103066_bib0060","article-title":"Industrializing autologous adoptive immunotherapies: manufacturing advances and challenges","volume":"5","author":"Iyer","year":"2018","journal-title":"Front Med (Lausanne)."},{"issue":"1","key":"10.1016\/j.transci.2021.103066_bib0065","first-page":"85","article-title":"Large volume leukapheresis is efficient and safe even in small children up to 15 kg body weight","volume":"15","author":"Bojanic","year":"2017","journal-title":"Blood Transfus"},{"issue":"2","key":"10.1016\/j.transci.2021.103066_bib0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/leu.2010.248","article-title":"Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization","volume":"25","author":"Greenbaum","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.transci.2021.103066_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jca.21672","article-title":"Impact of good and poor mobilizers on hematopoietic progenitor cell collection efficiency and product quality","volume":"34","author":"Azzouqa","year":"2019","journal-title":"J Clin Apher"},{"issue":"16","key":"10.1016\/j.transci.2021.103066_bib0080","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"1556","key":"10.1016\/j.transci.2021.103066_bib0085","article-title":"Update on umbilical cord blood transplantation","volume":"6","author":"Ballen","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.transci.2021.103066_bib0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-61779-815-3_16","article-title":"Collection, processing, and banking of umbilical cord blood stem cells for transplantation and regenerative medicine","volume":"879","author":"Badowski","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.transci.2021.103066_bib0095","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1537-2995.2008.01688.x","article-title":"Loss of integrity of umbilical cord blood unit freezing bags: description and consequences","volume":"48","author":"Thyagarajan","year":"2008","journal-title":"Transfusion"},{"issue":"1\u20132","key":"10.1016\/j.transci.2021.103066_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2013.09.027","article-title":"Negative depletion of alpha\/beta+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation","volume":"155","author":"Locatelli","year":"2013","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.transci.2021.103066_bib0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOH.0b013e3283582340","article-title":"Negative depletion of CD3(+) and TcRalphabeta(+) t cells","volume":"19","author":"Handgretinger","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.transci.2021.103066_bib0110","first-page":"161","article-title":"Robust selections of various hematopoietic cell fractions on the CliniMACS plus instrument","volume":"1","author":"Panch","year":"2019","journal-title":"Clin Hematology Int"},{"issue":"5","key":"10.1016\/j.transci.2021.103066_bib0115","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/trf.13534","article-title":"How do I perform hematopoietic progenitor cell selection?","volume":"56","author":"Avecilla","year":"2016","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.transci.2021.103066_bib0120","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1701228","article-title":"Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting","volume":"21","author":"Handgretinger","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.transci.2021.103066_bib0125","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2002-04-1203","article-title":"Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia","volume":"101","author":"Lang","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2021.103066_bib0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2006.06140.x","article-title":"Haploidentical stem cell transplantation for children with acute leukaemia","volume":"134","author":"Marks","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2021.103066_bib0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrclinonc.2015.128","article-title":"Modern approaches to HLA-haploidentical blood or marrow transplantation","volume":"13","author":"Kanakry","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.transci.2021.103066_bib0140","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.bbmt.2013.07.013","article-title":"Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis","volume":"19","author":"Kanakry","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.transci.2021.103066_bib0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-015-2423-y","article-title":"Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings","volume":"94","author":"Tischer","year":"2015","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.transci.2021.103066_bib0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000088411","article-title":"The significance of minimal residual disease in stem cell grafts and the role of purging: is it better to purge in vivo or in vitro?","volume":"114","author":"Melillo","year":"2005","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.transci.2021.103066_bib0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.transci.2018.04.018","article-title":"Donor lymphocyte infusion in myeloid disorders","volume":"57","author":"Toprak","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.transci.2021.103066_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2019.01.016","article-title":"Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Zeiser","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"24","key":"10.1016\/j.transci.2021.103066_bib0165","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.18.02079","article-title":"Cost effectiveness of chimeric antigen receptor T-Cell therapy in multiply relapsed or refractory adult large B-Cell lymphoma","volume":"37","author":"Lin","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.transci.2021.103066_bib0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13045-019-0705-x","article-title":"Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia","volume":"12","author":"Zhao","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"18","key":"10.1016\/j.transci.2021.103066_bib0175","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-14-3321","article-title":"Multiplex genome-edited T-cell manufacturing platform for \u201cOff-the-Shelf\u201d adoptive T-cell immunotherapies","volume":"75","author":"Poirot","year":"2015","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.transci.2021.103066_bib0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.transci.2021.103066_bib0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ymthe.2017.02.005","article-title":"Integration of a CD19 CAR into the TCR alpha chain locus streamlines production of allogeneic gene-edited CAR t cells","volume":"25","author":"MacLeod","year":"2017","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.transci.2021.103066_bib0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00262-018-2281-2","article-title":"CRISPR\/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions","volume":"68","author":"Hu","year":"2019","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.transci.2021.103066_bib0195","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/trf.15287","article-title":"Effects of starting cellular material composition on chimeric antigen receptor T-cell expansion and characteristics","volume":"59","author":"Elavia","year":"2019","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.transci.2021.103066_bib0200","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/trf.14003","article-title":"Autologous lymphapheresis for the production of chimeric antigen receptor T cells","volume":"57","author":"Allen","year":"2017","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.transci.2021.103066_bib0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/hgtb.2016.120","article-title":"A rapid cell expansion process for production of engineered autologous CAR-T cell therapies","volume":"27","author":"Lu","year":"2016","journal-title":"Hum Gene Ther Methods"},{"issue":"8","key":"10.1016\/j.transci.2021.103066_bib0210","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1537-2995.2008.01756.x","article-title":"Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device","volume":"48","author":"Perseghin","year":"2008","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2021.103066_bib0215","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jcyt.2017.09.005","article-title":"Closed-system manufacturing of CD19 and dual-targeted CD20\/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center","volume":"20","author":"Zhu","year":"2018","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.transci.2021.103066_bib0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0958-1669(98)80029-3","article-title":"Lentiviruses as gene transfer agents for delivery to non-dividing cells","volume":"9","author":"Naldini","year":"1998","journal-title":"Curr Opin Biotechnol"},{"issue":"21","key":"10.1016\/j.transci.2021.103066_bib0225","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding","volume":"74","author":"O\u2019Doherty","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.transci.2021.103066_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.omtm.2017.02.003","article-title":"Vectofusin-1 promotes RD114-TR-Pseudotyped lentiviral vector transduction of human HSPCs and t lymphocytes","volume":"5","author":"Piovan","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.transci.2021.103066_bib0235","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.omtm.2018.11.010","article-title":"Development of a novel Anti-CD19 chimeric antigen receptor: a paradigm for an affordable CAR t cell production at academic institutions","volume":"12","author":"Castella","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"10.1016\/j.transci.2021.103066_bib0240","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ymthe.2019.01.018","article-title":"The emerging role of in vitro-transcribed mRNA in adoptive t cell immunotherapy","volume":"27","author":"Foster","year":"2019","journal-title":"Mol Ther"},{"issue":"7643","key":"10.1016\/j.transci.2021.103066_bib0245","doi-asserted-by":"crossref","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.transci.2021.103066_bib0250","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jcyt.2013.06.003","article-title":"Simplified process for the production of anti-CD19-CAR-engineered T cells","volume":"15","author":"Tumaini","year":"2013","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.transci.2021.103066_bib0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/CJI.0b013e31824e801f","article-title":"Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment","volume":"35","author":"Jin","year":"2012","journal-title":"J Immunother"},{"issue":"10","key":"10.1016\/j.transci.2021.103066_bib0260","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1089\/hum.2017.111","article-title":"Automated manufacturing of potent CD20-Directed chimeric antigen receptor t cells for clinical use","volume":"28","author":"Lock","year":"2017","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1016\/j.transci.2021.103066_bib0265","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00262-012-1262-0","article-title":"Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy","volume":"61","author":"Buhl","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.transci.2021.103066_bib0270","series-title":"Cellular and gene therapy guidances: FDA [Internet]","year":"2019"},{"issue":"2","key":"10.1016\/j.transci.2021.103066_bib0275","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12015-018-9866-1","article-title":"Biological products: cellular therapy and FDA approved products","volume":"15","author":"Golchin","year":"2019","journal-title":"Stem Cell Rev Rep."},{"issue":"15","key":"10.1016\/j.transci.2021.103066_bib0280","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/bloodadvances.2019000219","article-title":"Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy","volume":"3","author":"Shah","year":"2019","journal-title":"Blood Adv"},{"issue":"106","key":"10.1016\/j.transci.2021.103066_bib0285","article-title":"Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma","volume":"71","author":"Salem","year":"2018","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.transci.2021.103066_bib0290","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/trf.15349","article-title":"How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?","volume":"59","author":"Chen","year":"2019","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:24Z","timestamp":1761468684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1473050221000161"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103066","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of a cell processing laboratory to support hematopoietic stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103066"}}